Filing Details
- Accession Number:
- 0001209191-15-027999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-19 18:27:18
- Reporting Period:
- 2015-03-17
- Filing Date:
- 2015-03-19
- Accepted Time:
- 2015-03-19 18:27:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402604 | Gil Bokkelen Van | 3201 Carnegie Avenue Cleveland OH 44115 | Chmn & Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-17 | 1,895 | $3.07 | 893,733 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-18 | 19,027 | $3.09 | 874,706 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-18 | 4,750 | $3.08 | 869,956 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-19 | 4,750 | $3.12 | 865,206 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares withheld from the quarterly vesting of a June 2014 restricted stock unit award related to the minimum tax withholding obligation.
- Shares withheld from the quarterly vesting of a June 2013 restricted stock unit award related to the minimum tax withholding obligation.
- Shares sold pursuant to a predefined Rule 10b5-1 trading plan solely related to the tax obligation on the quarterly vesting of a June 2013 restricted stock unit award.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.02 to $3.13, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.20, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
- Securities beneficially owned are comprised of: (1) 500,596 shares of common stock owned, (2) unvested 289,600 restricted stock units awarded in June 2013 related to the termination of 2005 incentive agreements that will vest ratably on a quarterly basis through June 18, 2016, and (3) unvested restricted stock units awarded on an annual basis amounting to 75,010 that vest quarterly over a four-year period from grant date.